| 000 | 01724 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513203401.0 | ||
| 264 | 0 | _c20000308 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0950-2688 | ||
| 024 | 7 |
_a10.1017/s0950268899003143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, I | |
| 245 | 0 | 0 |
_aOutbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. _h[electronic resource] |
| 260 |
_bEpidemiology and infection _cDec 1999 |
||
| 300 |
_a373-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
| 650 | 0 | 4 | _aCarrier State |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xclassification |
| 650 | 0 | 4 |
_aNorway _xepidemiology |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 650 | 0 | 4 | _aStudents |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aLehmann, A K | |
| 700 | 1 | _aLie, L | |
| 700 | 1 | _aDigranes, A | |
| 700 | 1 | _aCaugant, D A | |
| 700 | 1 | _aHøiby, E A | |
| 700 | 1 | _aFrøholm, L O | |
| 700 | 1 | _aHalstensen, A | |
| 773 | 0 |
_tEpidemiology and infection _gvol. 123 _gno. 3 _gp. 373-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/s0950268899003143 _zAvailable from publisher's website |
| 999 |
_c10648323 _d10648323 |
||